Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
706.25
-5.45 (-0.77%)
BSENSE

May 13

BSE+NSE Vol: 1.76 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "706.25",
    "chg": -5.45,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "711.70",
    "mcapval": "6,458.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0LRU01027",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "1.76 lacs",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Aarti Pharmalabs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aarti-pharmalabs-ltd-3988232",
        "imagepath": "",
        "date": "2026-05-12 23:17:41",
        "description": "The next results date for Aarti Pharmalabs Ltd is scheduled for 18 May 2026...."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-3986680",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_technicaldot_3986680.png",
        "date": "2026-05-12 08:08:56",
        "description": "Aarti Pharmalabs Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both bullish and bearish signals across different timeframes."
      },
      {
        "title": "Aarti Pharmalabs Declines 4.83% Amid Mixed Technical Signals: 2 Key Factors This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-declines-483-amid-mixed-technical-signals-2-key-factors-this-week-3982994",
        "imagepath": "",
        "date": "2026-05-09 11:01:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high surge to Rs.797.35 (+7.25%)</p>\n                    <p><strong>5 May:</strong> Strong price rally closing at Rs.805.70 (+8.26%)</p>\n                    <p><strong>6 May:</strong> Partial recovery to Rs.788.50 (+2.15%)</p>\n                    <p><strong>7 May:</strong> Decline to Rs.776.60 (-1.51%)</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.766.80 (-1.26%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.805.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3981444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_mojoScore_3981444.png",
        "date": "2026-05-08 10:10:44",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Aarti Pharmalabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3975031",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_technicaldot_3975031.png",
        "date": "2026-05-05 08:08:04",
        "description": "Aarti Pharmalabs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, supported by a blend of bullish and bearish signals across key indicators. The stock’s recent surge of 8.26% in a single day to ₹805.70 reflects renewed investor interest, yet technical analysis reveals a complex picture that demands careful scrutiny."
      },
      {
        "title": "Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-hits-intraday-high-with-725-surge-on-4-may-2026-3974171",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_priceRelatedfactors_3974171.png",
        "date": "2026-05-04 14:16:03",
        "description": "The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals &amp; Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3964139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_mojoScore_3964139.png",
        "date": "2026-04-27 10:11:18",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Aarti Pharmalabs Gains 1.10%: Technical Shift and Financial Challenges Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-gains-110-technical-shift-and-financial-challenges-shape-week-3952166",
        "imagepath": "",
        "date": "2026-04-18 11:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Stock opens at Rs.693.75, gains 0.69% despite Sensex decline</p>\n                    <p><strong>15 Apr:</strong> MarketsMOJO upgrades rating to Sell; stock rises 1.27%</p>\n                    <p><strong>16 Apr:</strong> Technical momentum shifts; stock dips 0.44% amid mixed signals</p>\n                    <p><strong>17 Apr:</strong> Week closes at Rs.696.60, down 0.41% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.693.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      },
      {
        "title": "Aarti Pharmalabs Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3948670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_mojoScore_3948670.png",
        "date": "2026-04-16 08:49:39",
        "description": "Aarti Pharmalabs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly more favourable outlook amid persistent operational headwinds and valuation considerations."
      }
    ],
    "total": 294,
    "sid": "1003784",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of Final Dividend If Any.",
      "datetime": "11-May-2026",
      "details": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve The Audited Financial Results for the quarter and financial year ended March 31 2026 and recommendation of Final Dividend if any.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Apr-2026",
      "details": "Newspaper Advertisement for the Second 100-Day Campaign - Saksham Niveshak",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Please find our intimation on captioned subject",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "18 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26",
          "dt": "2026-02-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Aarti Pharmalabs Declines 4.83% Amid Mixed Technical Signals: 2 Key Factors This Week

2026-05-09 11:01:57

Key Events This Week

4 May: Intraday high surge to Rs.797.35 (+7.25%)

5 May: Strong price rally closing at Rs.805.70 (+8.26%)

6 May: Partial recovery to Rs.788.50 (+2.15%)

7 May: Decline to Rs.776.60 (-1.51%)

8 May: Week closes at Rs.766.80 (-1.26%)

stock-recommendationAnnouncement

Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of Final Dividend If Any.

11-May-2026 | Source : BSE

Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve The Audited Financial Results for the quarter and financial year ended March 31 2026 and recommendation of Final Dividend if any.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Apr-2026 | Source : BSE

Newspaper Advertisement for the Second 100-Day Campaign - Saksham Niveshak

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Apr-2026 | Source : BSE

Please find our intimation on captioned subject

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

18 May 2026

stock-summary
DIVIDEND

Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available